This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Canine Atopic Dermatitis Treatment Market

Market Insights on Canine Atopic Dermatitis Treatment covering sales outlook, demand forecast & up-to-date key trends

Canine Atopic Dermatitis Treatment by Drug Class (Corticosteroids, Immunosuppressants, Antibiotics, Antihistamines, Emollients, Essential Fatty Acids, Antipruritics, Monoclonal Antibodies), Route of Administration (Topical, Oral, Injectable) & Region for 2022-2029

Canine Atopic Dermatitis Treatment Outlook – 2022-2029

[213 Pages Report] The global Canine Atopic Dermatitis Treatment Market is estimated to exceed US$ 2.37 Bn by the end of 2029. Growing emphasis on the development of novel therapeutics such as monoclonal antibodies for the treatment of atopic dermatitis in dogs and cats is expected to favor the growth in the market.

Attribute

Details

Canine Atopic Dermatitis Treatment Market Estimated Size in 2022

US$ 1.05 Bn

Canine Atopic Dermatitis Treatment Market Projected Size in 2029

US$ 2.37 Bn

Canine Atopic Dermatitis Treatment Market Historical CAGR (2014-2021)

13.8%

Canine Atopic Dermatitis Treatment Market Value-based CAGR (2022-2029)

12.3%

As per a detailed study by Future Market Insights, the demand in the global canine atopic dermatitis treatment market is projected to total US$ 1.05 Bn by 2022, surging at an impressive CAGR of 12.3% over the forecast period 2022-2029.

FMI estimates that North America will emerge as the most remunerative canine atopic dermatitis treatment market, creating an incremental opportunity of US$ 1 Bn through 2029. Based on the route of administration, the oral segment is anticipated to dominate the market, accounting for nearly 48.2% of the revenue share by 2022.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

12.47%

H1, 2022 Projected

12.30%

H1, 2022 Outlook

11.20%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 110 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 127 ↓

According to Future Market Insight analysis, the global canine atopic dermatitis treatment market expects to drop by 127 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 110 BPS.

The market decline observed through the drop in the BPS values is addressed by the adverse effects associated with the therapy, the high cost of treatment, and low efficacy in some cases. The global canine atopic dermatitis treatment market is subject to drug safety guidelines and safety, in accordance to the macro and industrial scale factors.

Furthermore, the market is highly influenced by stringent policies for regulation and licensing of drugs and molecular entities used for clinical purposes. The key developments in the market include the development of Cytopoint, an innovative therapy for the treatment of atopic dermatitis in canines by targeting the source of the itch. Conversely, the development of monoclonal antibodies for treatment of veterinary diseases is further expected to propel the market growth.

2014-2021 Canine Atopic Dermatitis Treatment Market Outlook In Comparison To 2022-2029 Growth Forecast

The global canine atopic dermatitis treatment market grew at 13.8% CAGR over the assessment period 2014-2029. The sales of canine atopic dermatitis treatment are estimated to rise by 2.2x between 2022 and 2029.

Canine atopic dermatitis is an inflammatory, allergic, chronic skin disease found in cats and dogs caused due to contact with harmless substances such as mold spores, house dust mites, grass, and other environmental allergens. Hence, increasing number of initiatives by animal protection organizations to spread awareness regarding the severity and early diagnostics & treatment of canine atopic dermatitis is expected to favor the growth in the market.

Canine Atopic Dermatitis Treatment Market Download Report Brochure

In addition, growing number of veterinary practitioners, especially across developed countries such as the U.S., Germany, the U.K., and others is propelling the demand for canine atopic dermatitis treatment. Driven by this, the global canine atopic dermatitis treatment market is projected to exceed US$ 2.37 Bn by the end of 2029.

How Will Rising Pet Ownership Unfold Canine Atopic Dermatitis Treatment Market Growth?

As the trend of pet humanization trend continues to create deeper inroads, a significant rise in adoption of pet animals such as cats, dogs, birds, fishes, and others is being witnessed across the globe. For instance, according to the America Society for the Prevention of Cruelty to Animals, nearly 2.1 million cats and 2 million dogs are adopted across the country every year.

Also, around 63.4 million households across the U.S. at least owns a dog in 2020. In addition to this, increasing concerns regarding animal health and rising susceptibility to various allergens such as airborne pollens, animal danders, and others are favoring the demand for canine atopic dermatitis treatment.

FMI reveals that the sales in the global canine atopic dermatitis treatment market are estimated to rise at a CAGR of 12.3% over the forecast period 2022-2029.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How Is Growing Burden Of Skin Diseases In Pets Augmenting Growth In The Market?

Increasing prevalence of skin allergies diseases such as atopic dermatitis in pets such as dogs and cats is the primary factor favoring the growth in the market. According to a report by the Canadian Veterinary Medical Association, nearly 3.3% of 27% of the canine population including cats and dogs are affected by skin allergies, skin inflammation, atopic dermatitis, and others across Canada.

Hence, a number of leading players are increasingly focusing on new therapeutics launches and receiving product approval for addressing the demand for advanced atopic dermatitis treatments.

For instance, in 2018, Zoetis, an American producer of medicine and vaccinations for pets, announced receive regulatory approval from the U.S. Food and Drug Administration (FDA) for its new monoclonal antibody (mAb) therapy, Cytopoint, for the treatment of allergic dermatitis in dogs. A slew of such product approvals is estimated to facilitate the growth in the market.

Country-Wise Analysis

Why is the Sales of Canine Atopic Dermatitis Treatment Accelerating in Germany?

“Rising Number of Veterinarians to Elevate the Sales of Canine Atopy Dog Treatment”

Germany is anticipated to emerge as a highly remunerative canine atopic dermatitis treatment market in Europe over the forecast period 2022 and 2029.

Increasing government emphasis on enhancing animal healthcare services and veterinary public health has resulted in significant rise in number of veterinarians across Germany. For instance, according to the Federation of Veterinarians of Europe, around 41,000 veterinarians were reported across Germany in 2018. This, along with the presence of favorable government policies for animal health is expected to favor the sales of canine atopy dog treatment in the Germany market.

Why is the Canine Atopic Dermatitis Treatment Market Expanding in the U.S.?

“Growing Emphasis on Development of Effective Therapeutics to Elevate the Atopic Dermatitis Dogs Treatment Sales”

The U.S. is projected to continue dominating the canine atopic dermatitis treatment market in North America, assisting the region to create an incremental opportunity of US$ 1 Bn between 2022 and 2029.

With increasing prevalence of canine atopic dermatitis across the U.S., leading players in the market are increasingly focusing on entering into agreements with other companies to developing more effective therapeutics.

For instance, in January 2020, Boragen Inc., an America boron-based discovery platform, announced entering into an exclusive research and development (R&D) agreement with an Animal Healthcare Leader for the discovery and development of advanced canine atopic dermatitis treatment. Such developments are estimated to spur the sales of atopic dermatitis dogs treatment in the U.S.

What are the Factors Facilitating Australia Canine Atopic Dermatitis Treatment Market Growth?

“Rising Trend of Pet Humanization to Bolster the Demand for Canine Dermatitis Treatment”

Australia is estimated to account for a significant share in the Oceania canine atopic dermatitis treatment market by the end of 2029, reveals FMI.

With surging trend of pet humanization, a substantial rise in adoption of pets such as dogs and cats is being witnessed across the country. For instance, according to the Royal Society for the Prevention of Cruelty to Animals, nearly 61% of the household across Australia owns pets, with dog being the most owned animal, accounting for nearly 40% of the total pet adoption in 2020.

In addition, increasing customer preference towards adopting dog breeds such as German Shepherd, Golden Retriever, Pug, and Labrador, which are highly susceptible to this canine atopic dermatitis is propelling the demand for canine dermatitis treatment in the Australia market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-Wise Insights

Why are Immunosuppressant Drugs Gaining Popularity in the Market?

“Immunosuppressant Drugs Segment to Account for the Maximum Canine Dermatitis Treatment Sales”

As per Future Market Insights, the immunosuppressant drugs segment is estimated to register robust growth in the global market, accounting for more than 45% of the canine atopic dermatitis treatment sales over the assessment period.

Apart from this, the monoclonal antibodies (mAb) segment is anticipated to account for a significant share in the market through 2029. Growing preference towards adopting mAb, owing to their high biological specificity is favoring the sales of canine dermatitis treatment across the segment.

Which Route of Administration Segment will Register Rapid Growth in the Market?

“Introduction of Novel Immune-specific Drugs to Spur the Sales of Atopic Dermatitis Dog Medication”

On the basis of route of administration, the global canine atopic dermatitis treatment market is segmented into topical, oral, and injectable. FMI reveals that the oral segment is estimated to dominate the global market, accounting for around 48.2% of the revenue share by 2022.

Increasing introduction of novel oral immune-specific drugs and rising adoption of these drugs owing to their ease of use on pets are factors favoring the growth in the segment. Besides this, the injectable segment is estimated to account for 34.2% of the atopic dermatitis dog medication sales through 2022.

Why are the Sales of Canine Atopic Dermatitis Treatment Rising Across the Retail Pharmacies Segment?

“Sales of Atopic Dermatitis Dogs Treatment to Concentrate Across the Retail Pharmacies Segment”

FMI states that the retail pharmacies segment is expected to exhibit growth at a rapid CAGR, accounting for more than 50% of the canine atopic dermatitis treatment sales during the forecast period 2022-2029.

Rising customer preference towards adopting oral administration of veterinary medicine and increasing availability of advanced oral medications across retail pharmacies is accelerating the sales of atopic dermatitis dogs treatment across the segment.

Competitive Landscape

Leading players operating in the global canine atopic dermatitis treatment market are focusing on research and development activities for launching novel treatment medication. Also, other companies are aiming strategies such as collaboration, merger, agreement, and acquisition for strengthen their footprint in the market. For instance,

  • In December 2020, Kindred Biosciences, Inc., an animal-specific biopharmaceutical organization, announced signing an agreement with manufacturer of medicines and vaccinations for pets, Elanco Animal Health for obtaining exclusive rights for monoclonal antibody targeting canine parvovirus, KIND-030.

Scope Of The Report

Attribute

Details

Forecast Period

2022-2029

Historical Data Available for

2014-2021

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Poland, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Vietnam, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, South Africa

Key Segments Covered

Drug Class, Route of Administration, Distribution Channel, and Region

Key Companies Profiled

Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Canine Atopic Dermatitis Treatment Market By Category

By Drug Class :

  • Corticosteroids
  • Immunosuppressants
  • Antibiotics
  • Antihistamines
  • Emollients
  • Essential Fatty Acids
  • Antipruritics
  • Monoclonal Antibodies

By Route of Administration :

  • Topical
  • Oral
  • Injectable

By Distribution Channel :

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Drug Stores
  • Mail Order Pharmacies

By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The canine atopic dermatitis treatment market is expected to surpass a valuation of US$ 1.05 Bn in 2022.

The global canine atopic dermatitis treatment market grew at a 13.8% CAGR over the past assessment period 2014-2021.

The canine atopic dermatitis treatment market is expected to register remarkable growth, expanding at 12.3% CAGR between 2022 and 2029.

North America currently leads the global canine atopic dermatitis treatment market, accounting sales of total US$ 1 Bn through 2029.

South Asia canine atopic dermatitis treatment market will hold a significant share over the assessment period 2022-2029.

In terms of route of administration, the oral segment is expected to account for maximum sales in the global canine atopic dermatitis treatment market through 2029.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Market Trends

    1.3. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Global Canine Atopic Dermatitis Treatment Market Demand Analysis 2014-2021 and Forecast, 2022-2029

    3.1. Historical Market Value (US$ Mn) Analysis, 2014-2021

    3.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029

        3.2.1. Y-o-Y Growth Trend Analysis

        3.2.2. Absolute $ Opportunity Analysis

4. Market Background

    4.1. Macro-Economic Factors

    4.2. Forecast Factors - Relevance & Impact

    4.3. Value Chain

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunity Analysis

5. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Treatment Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014 - 2021

    5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2022-2029

        5.3.1. Corticosteroids

        5.3.2. Immunosuppressant

        5.3.3. Antibiotics

        5.3.4. Antihistamines

        5.3.5. Emollients

        5.3.6. Essential Fatty Acids

        5.3.7. Antipruritics

        5.3.8. Monoclonal Antibody

    5.4. Market Attractiveness Analysis By Treatment Type

6. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Route of Administration

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014 - 2021

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2022 - 2029

        6.3.1. Oral

        6.3.2. Topical

        6.3.3. Injectable 

    6.4. Market Attractiveness Analysis By Route of Administration

7. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Distributional Channel

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Distributional Channel, 2014 - 2021

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distributional Channel, 2022 - 2029

        7.3.1. Veterinary Hospitals 

        7.3.2. Veterinary Clinics

        7.3.3. Retail Pharmacies

        7.3.4. Drug Stores

        7.3.5. Mail Over Pharmacies

    7.4. Market Attractiveness Analysis By Distributional Channel

8. Global Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029, by Region

    8.1. Introduction

    8.2. Historical Market Size (US$ Mn)  Analysis By Region, 2014 - 2021

    8.3. Current Market Size (US$ Mn)  Analysis and Forecast By Region, 2022 - 2029

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. East Asia

        8.3.5. South Asia

        8.3.6. Oceania

        8.3.7. Middle East and Africa 

    8.4. Market Attractiveness Analysis By Region

9. North America Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    9.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        9.3.1.  By Country

            9.3.1.1. U.S.

            9.3.1.2. Canada

        9.3.2. By Treatment Type

        9.3.3. By Route of Administration

        9.3.4. By Distributional Channel

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Treatment Type

        9.4.3. By Route of Administration

        9.4.4. By Distributional Channel

    9.5. Drivers and Restraints - Impact Analysis

10. Latin America Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    10.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        10.3.1. By Country

            10.3.1.1. Brazil

            10.3.1.2. Mexico

            10.3.1.3. Rest of Latin America

        10.3.2. By Treatment Type

        10.3.3. By Route of Administration

        10.3.4. By Distributional Channel

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Treatment Type

        10.4.3. By Route of Administration

        10.4.4. By Distributional Channel

    10.5. Drivers and Restraints - Impact Analysis

11. Europe Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        11.3.1. By Country

            11.3.1.1. Germany

            11.3.1.2. Italy

            11.3.1.3. France

            11.3.1.4. U.K.

            11.3.1.5. Spain

            11.3.1.6. BENELUX

            11.3.1.7. Russia

            11.3.1.8. Rest of Europe

        11.3.2. By Treatment Type

        11.3.3. By Route of Administration

        11.3.4. By Distributional Channel

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Treatment Type

        11.4.3. By Route of Administration

        11.4.4. By Distributional Channel

    11.5. Drivers and Restraints - Impact Analysis

12. South Asia Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        12.3.1.  By Country

            12.3.1.1. India

            12.3.1.2. Thailand

            12.3.1.3. Indonesia

            12.3.1.4. Malaysia

            12.3.1.5. Rest of South Asia

        12.3.2. By Treatment Type

        12.3.3. By Route of Administration

        12.3.4. By Distributional Channel

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Treatment Type

        12.4.3. By Route of Administration

        12.4.4. By Distributional Channel

    12.5. Drivers and Restraints - Impact Analysis

13. East Asia Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        13.3.1.  By Country

            13.3.1.1. China

            13.3.1.2. Japan

            13.3.1.3. South Korea

        13.3.2. By Treatment Type

        13.3.3. By Route of Administration

        13.3.4. By Distributional Channel

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Treatment Type

        13.4.3. By Route of Administration

        13.4.4. By Distributional Channel

    13.5. Drivers and Restraints - Impact Analysis

14. Oceania Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        14.3.1.  By Country

            14.3.1.1. Australia

            14.3.1.2. New Zealand

        14.3.2. By Treatment Type

        14.3.3. By Route of Administration

        14.3.4. By Distributional Channel

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Treatment Type

        14.4.3. By Route of Administration

        14.4.4. By Distributional Channel

    14.5. Drivers and Restraints - Impact Analysis

15. Middle East and Africa Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021

    15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029

        15.3.1.  By Country

            15.3.1.1. GCC Countries

            15.3.1.2. Turkey

            15.3.1.3. Northern Africa

            15.3.1.4. South Africa

            15.3.1.5. Rest of Middle East and Africa

        15.3.2. By Treatment Type

        15.3.3. By Route of Administration

        15.3.4. By Distributional Channel

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Treatment Type

        15.4.3. By Route of Administration

        15.4.4. By Distributional Channel

    15.5. Drivers and Restraints - Impact Analysis

16. Emerging Countries Canine Atopic Dermatitis Treatment Market Analysis 2014-2021 and Forecast 2022-2029

    16.1. Introduction

        16.1.1. Market Value Proportion Analysis, By Key Countries

        16.1.2. Global Vs. Country Growth Comparison

    16.2. China Canine Atopic Dermatitis Treatment Market Analysis

        16.2.1. Introduction

        16.2.2. PEST Analysis

        16.2.3. Market Value Proportion Analysis by Market Taxonomy

        16.2.4. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            16.2.4.1. By Treatment Type

            16.2.4.2. By Route of Administration

            16.2.4.3. By Distributional Channel

    16.3. India Canine Atopic Dermatitis Treatment Market Analysis

        16.3.1. Introduction

        16.3.2. PEST Analysis

        16.3.3. Market Value Proportion Analysis by Market Taxonomy

        16.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            16.3.4.1. By Treatment Type

            16.3.4.2. By Route of Administration

            16.3.4.3. By Distributional Channel

    16.4. Russia Canine Atopic Dermatitis Treatment Market Analysis

        16.4.1. Introduction

        16.4.2. PEST Analysis

        16.4.3. Market Value Proportion Analysis by Market Taxonomy

        16.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            16.4.4.1. By Treatment Type

            16.4.4.2. By Route of Administration

            16.4.4.3. By Distributional Channel

17. Competition Analysis

    17.1. Company Share Analysis (2021)

    17.2. Competition Dashboard

    17.3. Competition Deep Dive 

        17.3.1. Elanco Animal Health (Eli Lily and Company)  

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.1.4. Sales Footprint

            17.3.1.5. Strategy Overview

                17.3.1.5.1. Marketing Strategy

                17.3.1.5.2. Product Strategy

                17.3.1.5.3. Channel Strategy

        17.3.2. Ceva (Ceva Biovac)

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.2.4. Sales Footprint

            17.3.2.5. Strategy Overview

                17.3.2.5.1. Marketing Strategy

                17.3.2.5.2. Product Strategy

                17.3.2.5.3. Channel Strategy

        17.3.3. Zoetis Inc.

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.3.4. Sales Footprint

            17.3.3.5. Strategy Overview

                17.3.3.5.1. Marketing Strategy

                17.3.3.5.2. Product Strategy

                17.3.3.5.3. Channel Strategy

        17.3.4. Merck & Co., Inc.

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.4.4. Sales Footprint

            17.3.4.5. Strategy Overview

                17.3.4.5.1. Marketing Strategy

                17.3.4.5.2. Product Strategy

                17.3.4.5.3. Channel Strategy

        17.3.5. Virbac

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.5.4. Sales Footprint

            17.3.5.5. Strategy Overview

                17.3.5.5.1. Marketing Strategy

                17.3.5.5.2. Product Strategy

                17.3.5.5.3. Channel Strategy

        17.3.6. Boehringer Ingelheim GmbH (Merial)

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.6.4. Sales Footprint

            17.3.6.5. Strategy Overview

                17.3.6.5.1. Marketing Strategy

                17.3.6.5.2. Product Strategy

                17.3.6.5.3. Channel Strategy

        17.3.7. Sun Pharmaceutical Industries Ltd.

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.7.4. Sales Footprint

            17.3.7.5. Strategy Overview

                17.3.7.5.1. Marketing Strategy

                17.3.7.5.2. Product Strategy

                17.3.7.5.3. Channel Strategy

        17.3.8. Johnson & Johnson Services, Inc.

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.8.4. Sales Footprint

            17.3.8.5. Strategy Overview

                17.3.8.5.1. Marketing Strategy

                17.3.8.5.2. Product Strategy

                17.3.8.5.3. Channel Strategy

        17.3.9. Pfizer Inc.

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            17.3.9.4. Sales Footprint

            17.3.9.5. Strategy Overview

                17.3.9.5.1. Marketing Strategy

                17.3.9.5.2. Product Strategy

                17.3.9.5.3. Channel Strategy

    17.4. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 02: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 03: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 04: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region

Table 05: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 06: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 07: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 08: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 09: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 10: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 11: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 12: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 13: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 14: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 15: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 16: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 17: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 18: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 19: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 20: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 21: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 22: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 23: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 24: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 25: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 26: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 27: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 28: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 29: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country

Table 30: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 31: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 32: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 33: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 34: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 35: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 36: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 37: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 38: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Table 39: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Drug Class

Table 40: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Route of Administration 

Table 41: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Historical Canine Atopic Dermatitis Treatment Historical Market Size 2014-2021

Figure 02: Global Canine Atopic Dermatitis Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029

Figure 03: Global Canine Atopic Dermatitis Treatment Market Absolute $ Opportunity, 2014–2029

Figure 04: Global Canine Atopic Dermatitis Treatment Market Share Analysis (%) By Drug Class, 2022 & 2029

Figure 05: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Drug Class, 2022–2029

Figure 06: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 07: Global Canine Atopic Dermatitis Treatment Market Share Analysis (%) By Route of Administration, 2022 & 2029

Figure 08: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Route of Administration, 2022–2029

Figure 09: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration 

Figure 10: Global Canine Atopic Dermatitis Treatment Market Analysis by Distribution Channel –2022 & 2029

Figure 11: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029

Figure 12: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 13: Global Canine Atopic Dermatitis Treatment Market Share Analysis (%) By Region, 2022 & 2029

Figure 14: Global Canine Atopic Dermatitis Treatment Market Y-o-Y Growth (%) By Region, 2022–2029

Figure 15: Global Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Region

Figure 16: North America Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 17: North America Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 18: North America Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 19: North America Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 20: North America Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 21: North America Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 22: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 23: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 24: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 25: North America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 26: Latin America Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 27: Latin America Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 28: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 29: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 30: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 31: Latin America Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 32: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 33: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 34: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 35: Latin America Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 36: Europe Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 37: Europe Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 38: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 39: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 40: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 41: Europe Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 42: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 43: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 44: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 45: Europe Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 46: South Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 47: South Asia Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 48: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 49: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 50: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 51: South Asia Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 52: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 53: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 54: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 55: South Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 56: East Asia Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 57: East Asia Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 58: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 59: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 60: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 61: East Asia Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 62: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 63: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 64: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 65: East Asia Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 66: Oceania Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 67: Oceania Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 68: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 69: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 70: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 71: Oceania Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 72: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 73: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 74: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 75: Oceania Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 76: MEA Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 77: MEA Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 78: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Drug Class (2022 E)

Figure 79: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Route of Administration (2022 E)

Figure 80: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Distribution Channel (2022 E)

Figure 81: MEA Canine Atopic Dermatitis Treatment Market Value Share, By Country (2022 E)

Figure 82: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Drug Class

Figure 83: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Route of Administration

Figure 84: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Distribution Channel

Figure 85: MEA Canine Atopic Dermatitis Treatment Market Attractiveness Analysis, By Country

Figure 86: Emerging countries Canine Atopic Dermatitis Treatment Market Size (US$ Mn) Analysis, 2022

Figure 87: Emerging countries Canine Atopic Dermatitis Treatment Market Size (US$ Mn) 2014 – 2029

Figure 88: China Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 89: China Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 90: India Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 91: India Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Figure 92: Russia Canine Atopic Dermatitis Treatment Market Size (US$ Mn), 2014-2021

Figure 93: Russia Canine Atopic Dermatitis Treatment Market Size (US$) & Y-o-Y Growth (%), 2022–2029

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Feline Atopic Dermatitis Treatment Market

Published : June 2019

Healthcare

Atopic Dermatitis Treatment Market

Published : January 2022

Google translate

Canine Atopic Dermatitis Treatment Market